National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 1) (PB 4 of 2018) (Cth)

PB 4 of 2018

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 1)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated         22 January 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 1)

(2)This Instrument may also be cited as PB 4 of 2018.

2          Commencement

This Instrument commences on 1 February 2018.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1, omit entry for Cyproheptadine

1. Schedule 1, after entry for Raloxifene

insert:

Raltegravir Tablet 600 mg (as potassium) 20 120 5

1. Schedule 1

omit:

Testosterone Injection containing testosterone enanthate 250 mg in 1 mL 20 3 3